Therapeutic Delivery – News and Features

A collaborative team has created inhalable mucoadhesive protein nanoparticles inspired by mussel adhesive properties. These biocompatible particles enable targeted delivery of anticancer drugs to the lung cancer microenvironment.

Just as semaglutide products like Ozempic revolutionize the world of weight loss treatment, another fat-fighting injection emerges on the horizon.

Most diabetic wound care products are passive dressings, only providing a protective barrier against the external environment. This article explores how hydrogel technologies can promote diabetic wound healing.

New research by Oregon Health & Science University scientists has uncovered multiple factors to improve gene delivery to the kidney by adeno-associated virus vectors.

Researchers have modified lipid nanoparticles to enable them to cross the blood–brain barrier and target neural cells, marking a step toward next-generation treatments for neurological diseases.

Cell and gene therapies are revolutionizing medicine. Looking to 2025, advancements in allogeneic therapies, streamlined autologous processes and broader applications promise increased accessibility and innovation in treating complex diseases.

A bacterium that exists on the skin of nearly everyone on Earth could be transformed into a topical vaccine.

This article explores how 4D printing uses biomaterials to create shape-shifting medical devices, adaptive tissue scaffolds and targeted drug delivery systems.

Targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer adverse side effects.

A new approach to treat rosacea and other inflammatory skin conditions by inhibiting mast cells could be on the horizon.